Tech Company Financing Transactions

Karyopharm Therapeutics Funding Round

On 11/2/2011, Karyopharm Therapeutics raised $10 million in Series A funding from private investors.

Transaction Overview

Announced On
11/2/2011
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will be used to expand the planned Phase I program, targeted to begin in mid 2012 with Karyopharm's oral selective inhibitors of nuclear export (SINE) for various cancers.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
85 Wells Ave. 2nd Floor
Newton, MA 02459
USA
Email Address
Overview
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.
Profile
Karyopharm Therapeutics LinkedIn Company Profile
Social Media
Karyopharm Therapeutics Company Twitter Account
Company News
Karyopharm Therapeutics News
Facebook
Karyopharm Therapeutics on Facebook
YouTube
Karyopharm Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Kauffman
  Michael Kauffman LinkedIn Profile  Michael Kauffman Twitter Account  Michael Kauffman News  Michael Kauffman on Facebook
Chief Operating Officer
Ran Frenkel
  Ran Frenkel LinkedIn Profile  Ran Frenkel Twitter Account  Ran Frenkel News  Ran Frenkel on Facebook
Chief Scientific Officer
Sharon Shacham
  Sharon Shacham LinkedIn Profile  Sharon Shacham Twitter Account  Sharon Shacham News  Sharon Shacham on Facebook
Vice President
Brian Austad
  Brian Austad LinkedIn Profile  Brian Austad Twitter Account  Brian Austad News  Brian Austad on Facebook
VP - General Counsel
Christopher Primiano
  Christopher Primiano LinkedIn Profile  Christopher Primiano Twitter Account  Christopher Primiano News  Christopher Primiano on Facebook
VP - Operations
Ronit Milstein
  Ronit Milstein LinkedIn Profile  Ronit Milstein Twitter Account  Ronit Milstein News  Ronit Milstein on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/1/2011: Jivox venture capital transaction
Next: 11/2/2011: StellaService venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary